MEDS: TRxADE HEALTH, Inc. - Summary | Jitta

TRxADE HEALTH, Inc.

NASDAQ:MEDS

Notice
Stock data is unavailable or the company’s delisted.
Price
$12.79
Loss Chance
58.4%
0.15JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (21)
Recent Business Performance (11)
Financial Strength (40)
Return to Shareholders (4)
Competitive Advantage (14)
Jitta Signs
Revenue and EarningEarning loss detected in 2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 22.42% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
0.15
100.00%
2.03
295.17%
2.03
295.17%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of July 25, 2024, TRxADE HEALTH, Inc. was acquired by TRxADE HEALTH, Inc., in a reverse merger transaction. TRxADE HEALTH, Inc. operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace. It also distributes prescription medication, medical devices, and over the counter medication to pharmacies and medical clinics; and offers pricing transparency, purchasing capabilities, and other value-added services, as well as telehealth services. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. was founded in 2010 and is headquartered in Lutz, Florida.